Optimized DOPE/CHEMS pH-sensitive liposomes
DOPE/CHEMS 2.2:1 pH-sensitive liposomes with 0.5 mol% DSPE-PEG2000 and a 1:30 docetaxel-to-lipid molar ratio.
Applicable scenario
Research formulation for acidic-pH-responsive docetaxel release and endosomal escape studies. This is the optimized Optimal-D condition from Moreira et al.'s Box–Behnken design, not a generic DOPE/CHEMS ratio.
Import to Workspace
Open or scan to import into Workspace, jump to Modules and open this Recipe in the editor.
Formulation tables
Optimal-D composition
| Component | Ratio / concentration | Role |
|---|---|---|
| DOPE:CHEMS | 2.2:1 mol:mol | pH-sensitive membrane |
| DSPE-PEG2000 | 0.5 mol% | Fixed PEGylated component |
| Docetaxel:total lipid | 1:30 mol:mol | Payload-to-lipid ratio |
| Chloroform | 2 mL | Lipid-film solvent |
| PBS pH 7.4 | 5 mL | Lipid-film hydration |
Optimized condition and reported result
| Parameter | Value | Context |
|---|---|---|
| Sonication | 2.5 min at 40% amplitude; 5/2 on/off cycles | Optimal-D preparation |
| Encapsulation efficiency | 88.65% | Experimental result |
| Diameter | 107.17 nm | Experimental result |
| PDI | 0.213 | Experimental result |
Source values and calculations
- The optimized conditions are DOPE:CHEMS 2.2:1, DTX:total lipid 1:30 mol:mol and 2.5 min sonication.
- DSPE-PEG2000 is fixed at 0.5 mol% in the preparation method.
- The experimental optimized formulation achieved 88.65% encapsulation efficiency, 107.17 nm diameter and PDI 0.213; these are reported results, not guaranteed acceptance criteria.
Literature source
Moreira TDS et al. DOPE/CHEMS-Based EGFR-Targeted Immunoliposomes for Docetaxel Delivery: Formulation Development, Physicochemical Characterization and Biological Evaluation on Prostate Cancer Cells. Pharmaceutics 15, 915 (2023).
Source locator: Section 2.1, Preparation of pH-Sensitive Liposomes; Section 3, Optimal-D formulation
Read the original source · DOI: 10.3390/pharmaceutics15030915
Editorial source check: 2026-11-09. Verify the original publication, actual stock concentrations and local safety requirements before use. Research use only; not clinical instructions.